557 related articles for article (PubMed ID: 9218667)
1. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
[TBL] [Abstract][Full Text] [Related]
2. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Curb JD; Pressel SL; Cutler JA; Savage PJ; Applegate WB; Black H; Camel G; Davis BR; Frost PH; Gonzalez N; Guthrie G; Oberman A; Rutan GH; Stamler J
JAMA; 1996 Dec; 276(23):1886-92. PubMed ID: 8968014
[TBL] [Abstract][Full Text] [Related]
3. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.
JAMA; 1991 Jun; 265(24):3255-64. PubMed ID: 2046107
[TBL] [Abstract][Full Text] [Related]
4. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
5. Effect of treating isolated systolic hypertension on the risk of developing various types and subtypes of stroke: the Systolic Hypertension in the Elderly Program (SHEP).
Perry HM; Davis BR; Price TR; Applegate WB; Fields WS; Guralnik JM; Kuller L; Pressel S; Stamler J; Probstfield JL
JAMA; 2000 Jul; 284(4):465-71. PubMed ID: 10904510
[TBL] [Abstract][Full Text] [Related]
6. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
[TBL] [Abstract][Full Text] [Related]
7. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group.
Savage PJ; Pressel SL; Curb JD; Schron EB; Applegate WB; Black HR; Cohen J; Davis BR; Frost P; Smith W; Gonzalez N; Guthrie GP; Oberman A; Rutan G; Probstfield JL; Stamler J
Arch Intern Med; 1998 Apr; 158(7):741-51. PubMed ID: 9554680
[TBL] [Abstract][Full Text] [Related]
8. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
[TBL] [Abstract][Full Text] [Related]
9. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group.
Probstfield JL; Applegate WB; Borhani NO; Curb JD; Cutler JA; Davis BR; Furberg CD; Hawkins CM; Lakatos E; Page LB
Clin Exp Hypertens A; 1989; 11(5-6):973-89. PubMed ID: 2676266
[TBL] [Abstract][Full Text] [Related]
10. Association between chlorthalidone treatment of systolic hypertension and long-term survival.
Kostis JB; Cabrera J; Cheng JQ; Cosgrove NM; Deng Y; Pressel SL; Davis BR
JAMA; 2011 Dec; 306(23):2588-93. PubMed ID: 22187278
[TBL] [Abstract][Full Text] [Related]
11. Isolated systolic hypertension: lowering the risk of stroke in older patients. SHEP Cooperative Research Group.
Petrovitch H; Vogt TM; Berge KG
Geriatrics; 1992 Mar; 47(3):30-2, 35-8. PubMed ID: 1544585
[TBL] [Abstract][Full Text] [Related]
12. Implications of the systolic hypertension in the elderly program. The Systolic Hypertension in the Elderly Program Cooperative Research Group.
Hypertension; 1993 Mar; 21(3):335-43. PubMed ID: 8478043
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for stroke and type of stroke in persons with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.
Davis BR; Vogt T; Frost PH; Burlando A; Cohen J; Wilson A; Brass LM; Frishman W; Price T; Stamler J
Stroke; 1998 Jul; 29(7):1333-40. PubMed ID: 9660383
[TBL] [Abstract][Full Text] [Related]
14. Diuretic versus alpha-blocker as first-step antihypertensive therapy: final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group
Hypertension; 2003 Sep; 42(3):239-46. PubMed ID: 12925554
[TBL] [Abstract][Full Text] [Related]
15. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ;
JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465
[TBL] [Abstract][Full Text] [Related]
16. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
17. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Applegate WB; Pressel S; Wittes J; Luhr J; Shekelle RB; Camel GH; Greenlick MR; Hadley E; Moye L; Perry HM
Arch Intern Med; 1994 Oct; 154(19):2154-60. PubMed ID: 7944835
[TBL] [Abstract][Full Text] [Related]
18. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP).
Franse LV; Pahor M; Di Bari M; Shorr RI; Wan JY; Somes GW; Applegate WB
J Hypertens; 2000 Aug; 18(8):1149-54. PubMed ID: 10954008
[TBL] [Abstract][Full Text] [Related]
19. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes.
Kostis JB; Wilson AC; Freudenberger RS; Cosgrove NM; Pressel SL; Davis BR;
Am J Cardiol; 2005 Jan; 95(1):29-35. PubMed ID: 15619390
[TBL] [Abstract][Full Text] [Related]
20. Effect of treatment of isolated systolic hypertension on left ventricular mass.
Ofili EO; Cohen JD; St Vrain JA; Pearson A; Martin TJ; Uy ND; Castello R; Labovitz AJ
JAMA; 1998 Mar; 279(10):778-80. PubMed ID: 9508155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
